failure to respond or late response
on 07 Jan 2021
Last Applicant/ Owned by
704-595 HOWE STREET
VANCOUVER
CA
V6C2T5
Serial Number
86532961 filed on 12th Feb 2015
Registration Number
N/A
Correspondent Address
Kimberly N. Fisher
Filing Basis
1. intent to use
Disclaimer
NO DATA
Magnetically encoded cards for medical purposes, namely, membership and identification cards; magnetically encoded cards for use in connection with customer loyalty, rewards, bonus points, and discount programs Cannabis compounds for medicinal purposes and cannabis based pharmaceuticals and nutraceuticals comprised of legal cannabis products for the treatment of pain, palliative care, nausea and Read More
Medical research services; medical research services in the field of cannabis and medical marihuana; product development services
Operation of a computer database featuring medical information in the field of medical marihuana; operation of a website containing medical information in the field of marihuana and cannabis
Operation of a web site that provides online social networking
Cannabis compounds not for medicinal purposes comprised of legal cannabis products; unmedicated cannabis preparations and derivative products in the form of personal care preparations for the body, namely, creams, oils, emollients, ointments, rubs, lotions, and salves, comprised of legal cannabis products; unmedicated products, plants, dried plant material, seeds and medicines derived from and related to the cannabis plant, namely, anti-inflammatories, analgesics, sedatives, appetite stimulants, anti-nauseants, intraocular pressure reducers, anti-tumors antioxidants, antidepressants and antihypertensives comprised of legal cannabis products
Cannabis compounds for medicinal purposes and cannabis based pharmaceuticals and nutraceuticals comprised of legal cannabis products for the treatment of pain, palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, Multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritides and musculoskeletal disorders, movement disorders, glaucoma, asthma, hypertension, psychiatric disorders, anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, dementia, inflammation, inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; medicated cannabis preparations in the form of personal care preparations for the body, namely, creams, oils, emollients, ointments, rubs, lotions, and salves comprising legal cannabis products; synthetic narcotics for medical use; pharmaceutical preparations for the treatment of pain, palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, Multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritides and musculoskeletal disorders, movement disorders, glaucoma, asthma, hypertension, psychiatric disorders, anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, dementia, inflammation, inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; pharmaceutical preparations containing one or more legal cannabinoids as the active ingredient for the treatment of pain, palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, Multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritides and musculoskeletal disorders, movement disorders, glaucoma, asthma, hypertension, psychiatric disorders, anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, dementia, inflammation, inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; medicines containing a legal tetrahydrocannabinol extract for the treatment of pain, palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, Multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritides and musculoskeletal disorders, movement disorders, glaucoma, asthma, hypertension, psychiatric disorders, anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, dementia, inflammation, inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; medicines derived from legal cannabis for the treatment of pain, palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, Multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritides and musculoskeletal disorders, movement disorders, glaucoma, asthma, hypertension, psychiatric disorders, anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, dementia, inflammation, inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; nutraceuticals and medicines comprising legal cannabis products derived from and related to the cannabis plant for the treatment of pain, palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, Multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritides and musculoskeletal disorders, movement disorders, glaucoma, asthma, hypertension, psychiatric disorders, anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, dementia, inflammation, inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; medicated products, plants, dried plant material, seeds and medicines derived from and related to the cannabis plant, namely, anti-inflammatories, analgesics, sedatives, appetite stimulants, anti-nauseants, intraocular pressure reducers, anti-tumors antioxidants, antidepressants and antihypertensives comprised of legal cannabis products
Magnetically encoded cards for medical purposes, namely, membership and identification cards; magnetically encoded cards for use in connection with customer loyalty, rewards, bonus points, and discount programs
Medical dispensary featuring cannabis compounds for medicinal purposes and cannabis based pharmaceuticals and nutraceuticals comprised of legal cannabis products; online operation of a medical dispensary featuring cannabis compounds for medicinal purposes and cannabis based pharmaceuticals and nutraceuticals comprised of legal cannabis products; operation of a retail store featuring cannabis compounds for medicinal purposes and cannabis based pharmaceuticals and nutraceuticals comprised of legal cannabis products; retail and wholesale store reward programs, namely, arranging and conducting incentive reward programs to promote the sale of cannabis compounds for medicinal purposes and cannabis based pharmaceuticals and nutraceuticals comprised of legal cannabis products; promoting the goods and services of others by means of the issuance of loyalty rewards cards, namely, providing identification cards for use in connection with customer loyalty, rewards, bonus points, and discount programs
No 86532961
No Service Mark
No GWL413
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
07th Jan 2021 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
07th Jan 2021 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
26th Jun 2020 | FINAL REFUSAL E-MAILED |
26th Jun 2020 | NOTIFICATION OF FINAL REFUSAL EMAILED |
26th Jun 2020 | FINAL REFUSAL WRITTEN |
11th Jun 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
10th Jun 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
10th Jun 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
28th Jan 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
28th Jan 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |